---
content_type: resource
description: Gleevec (in red) is a drug used to treat chronic myeloid leukemia (CML).
  It works by inhibiting bcr-abl kinase (in green), the protein that causes CML. (Image
  courtesy of RCSB Protein Data Bank entry 1IEP.)
file: /courses/7-341-bench-to-bedside-molecularly-targeted-therapies-in-blood-disorders-and-malignancy-fall-2009/5d6d01e4b56a83cf06760537410e1ca7_7-341f09-th.jpg
file_size: 10550
file_type: image/jpeg
hide_download: true
hide_download_original: null
image_metadata:
  caption: Gleevec (in red) is a drug used to treat chronic myeloid leukemia (CML).
    It works by inhibiting bcr-abl kinase (in green), the protein that causes CML.
    (Image courtesy of [RCSB Protein Data Bank](http://www.rcsb.org/pdb/home/home.do)
    entry [1IEP](http://www.rcsb.org/pdb/explore/explore.do?pdbId=1IEP).)
  credit: ''
  image-alt: Ribbon diagram of the crystal structure of BCR-ABL kinase in complex
    with Gleevec.
learning_resource_types: []
license: https://creativecommons.org/licenses/by-nc-sa/4.0/
ocw_type: OCWImage
resourcetype: Image
title: Ribbon diagram of the crystal structure of BCR-ABL kinase in complex with Gleevec
uid: 5d6d01e4-b56a-83cf-0676-0537410e1ca7
---
Gleevec (in red) is a drug used to treat chronic myeloid leukemia (CML). It works by inhibiting bcr-abl kinase (in green), the protein that causes CML. (Image courtesy of RCSB Protein Data Bank entry 1IEP.)